23andMe and Genentech to analyze genomic data for Parkinson's disease
09-Jan-2015 -
23andMe, Inc. announced an agreement with Genentech to generate whole genome sequencing data for approximately 3,000 people in 23andMe's Parkinson's disease community. The goal of the collaboration is to identify new therapeutic targets for treating Parkinson's disease.This multi-year ...
Genentech
genome sequencing
Parkinson's disease